# CCTG BL12 (NCT02033993)

> Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02033993
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: Canadian Cancer Trials Group
- Conditions: Urothelial Cancer
- Interventions: Nab-Paclitaxel; Paclitaxel
- Enrollment: 199
- Primary outcome: Progression-Free Survival

## Indexed commentary on CCTG BL12 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=cctg-bl12-nct02033993